[{"_id":"551f89b731cae9239deb1f38","会社名":"カルナバイオサイエンス(株)【4572】","証券コード":"4572","決算期":"2014年12月期","会計方式":"日本方式","決算発表日":"2015年2月13日","決算月数":"12か月","売上高":"611百万円","営業利益":"-634百万円","経常利益":"-607百万円","当期利益":"-846百万円","EPS（一株当たり利益）":"-102.18円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"98.69円","総資産":"1,221百万円","自己資本":"821百万円","資本金":"2,627百万円","有利子負債":"159百万円","自己資本比率":"67.2%","ROA（総資産利益率）":"-54.42%","ROE（自己資本利益率）":"-70.24%","総資産経常利益率":"-39.05%","__v":0,"日付":"2015-04-04T06:50:31.665Z"},{"_id":"551f89b731cae9239deb1f39","会社名":"カルナバイオサイエンス(株)【4572】","証券コード":"4572","決算期":"2013年12月期","会計方式":"日本方式","決算発表日":"2014年2月7日","決算月数":"12か月","売上高":"771百万円","営業利益":"-300百万円","経常利益":"-276百万円","当期利益":"-282百万円","EPS（一株当たり利益）":"-36.59円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"192.13円","総資産":"1,888百万円","自己資本":"1,588百万円","資本金":"2,602百万円","有利子負債":"140百万円","自己資本比率":"84.1%","ROA（総資産利益率）":"-18.77%","ROE（自己資本利益率）":"-22.85%","総資産経常利益率":"-18.38%","__v":0,"日付":"2015-04-04T06:50:31.665Z"},{"_id":"551f89b731cae9239deb1f3a","会社名":"カルナバイオサイエンス(株)【4572】","証券コード":"4572","決算期":"2012年12月期","会計方式":"日本方式","決算発表日":"2013年2月8日","決算月数":"12か月","売上高":"510百万円","営業利益":"-457百万円","経常利益":"-442百万円","当期利益":"-449百万円","EPS（一株当たり利益）":"-7,328.33円","調整一株当たり利益":"---","BPS（一株当たり純資産）":"12,098.79円","総資産":"1,116百万円","自己資本":"880百万円","資本金":"2,270百万円","有利子負債":"133百万円","自己資本比率":"78.9%","ROA（総資産利益率）":"-36.91%","ROE（自己資本利益率）":"-47.29%","総資産経常利益率":"-36.33%","__v":0,"日付":"2015-04-04T06:50:31.666Z"}]